PAMELA KEY: Open Payments
NPI 1215454020 · CHATSWORTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 13 payments from 9 companies in 2025. Trend: 2023 $470 · 2024 $375 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Amgen Inc. | 2 | $29 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| CVRx, Inc. | 1 | $3 |
Products named: BodyGuardian, Kerendia, LEQVIO, REPATHA, WATCHMAN Access System, ELIQUIS, CAMZYOS, LifeVest.
Industry payments across GA — which companies pay providers there.
